Understanding The Role of The PARGP1 Gene in Diseases (G728407)

Target Name: PARGP1

NCBI ID: G728407

PARGP1

Other Name(s): poly(ADP-ribose) glycohydrolase pseudogene 1 | Poly(ADP-ribose) glycohydrolase pseudogene 1 | PRO1102

Understanding The Role of The PARGP1 Gene in Diseases

Poly(ADP-ribose) glycohydrolase (PARGP1) is a gene that encodes a protein known for its role in the regulation of intracellular signaling pathways. The PARGP1 gene has been identified as a potential drug target and a biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The PARGP1 gene is located on chromosome 12q34 and has been implicated in the development and progression of several diseases. Studies have shown that individuals with certain genetic variations in the PARGP1 gene are at an increased risk of developing these diseases. For example, individuals with the missense variation, which results in the substitution of a thymine base for a guanine base at position 198, are reported to have an increased risk of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its association with disease, the PARGP1 gene has also been shown to play a key role in the regulation of intracellular signaling pathways. The PARGP1 protein has been shown to interact with several intracellular signaling proteins, including Parkin, a protein that plays a role in the regulation of mitochondrial function and stress response.

The PARGP1 gene has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of tissues, such as the formation of blood vessels and the development of neural cells. The PARGP1 protein has been shown to play a role in the regulation of cell adhesion, as well as the formation of blood-brain barrier.

In addition to its role in intracellular signaling pathways, the PARGP1 gene has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of tissues. The PARGP1 protein has been shown to play a role in the regulation of cell adhesion, as well as the formation of blood-brain barrier.

The PARGP1 gene has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of tissues. The PARGP1 protein has been shown to play a role in the regulation of cell adhesion, as well as the formation of blood-brain barrier.

Despite its potential as a drug target and biomarker, the PARGP1 gene has not yet been studied extensively, and much of its function and significance remains to be determined. Further research is needed to fully understand the role of the PARGP1 gene in the development and progression of diseases, as well as its potential as a drug target and biomarker.

In conclusion, the PARGP1 gene has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its role in the regulation of intracellular signaling pathways, as well as its involvement in the regulation of cellular processes that are important for the development and maintenance of tissues, make it an attractive target for further research. Further studies are needed to fully understand its function and significance.

Protein Name: Poly(ADP-ribose) Glycohydrolase Pseudogene 1

The "PARGP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PARGP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets